Gd-DOTA conjugate of RGD as a potential tumor-targeting MRI contrast agent

Chembiochem. 2008 Nov 24;9(17):2811-3. doi: 10.1002/cbic.200800529.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line
  • Cell Survival / drug effects
  • Chickens
  • Contrast Media / chemical synthesis
  • Contrast Media / chemistry*
  • Contrast Media / toxicity
  • Genes, ras
  • Heterocyclic Compounds / chemistry*
  • Integrin alphaVbeta3 / metabolism
  • Liver Neoplasms, Experimental / diagnosis
  • Liver Neoplasms, Experimental / metabolism
  • Liver Neoplasms, Experimental / pathology
  • Magnetic Resonance Imaging / methods*
  • Mice
  • Mice, Transgenic
  • Neoplasm Transplantation
  • Oligopeptides / chemistry*
  • Organometallic Compounds / chemistry*
  • Protein Binding

Substances

  • Contrast Media
  • Heterocyclic Compounds
  • Integrin alphaVbeta3
  • Oligopeptides
  • Organometallic Compounds
  • arginyl-glycyl-aspartic acid
  • gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate